This is a preview of subscription content, log in via an institution to check access.
Reference
Northwest Biotherapeutics. NW Bio Announces Two German Approvals: Hospital Exemption for Early Access Program with DCVax-L and Eligibility of DCVax-L for Reimbursement. Media Release : 10 Mar 2014. Available from: URL: http://www.nwbio.com
Additional information
* Institut Fur Das Entgeltsystem Im Krankenhaus
Rights and permissions
About this article
Cite this article
DCVax-L now available for glioma patients in Germany. PharmacoEcon Outcomes News 699, 10 (2014). https://doi.org/10.1007/s40274-014-1146-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1146-y